HCI is led, advised and supported by people and organisations with experience across healthcare, policy, regulation, supply, digitalisation and sustainability.
Founding Members established HCI to create a neutral place for questions that cross organisational and sector boundaries. Their combined experience gives the Institute an end-to-end view of the healthcare chain.
Monika Derecque-Pois
Founder and Chief Executive
Former Director General of GIRP; former President and Board Member of EMVO.
Charles Gloor
Founding Partner, Birgli Ltd
Founder and former Head of Movianto; experienced global non-executive director and trustee.
Andrew Bonser
Founder and Director, Numaris Corporate Affairs
Former Senior Vice President at Cencora, with previous senior roles at WBA, Pfizer and Intuitive Surgical.
Lukas Pachinger
Biopharma Executive
More than 25 years of experience in international finance, supply chain and digital transformation.
Martin Fitzgerald
Founder. Managing Director FBS Ltd
Former Director, Digital Health and Public Policy Healthcare, GS1 former Deputy Director General of GIRP.
Advisory Board
The Advisory Board strengthens HCI’s work with independent expertise and perspectives from across the healthcare value chain. Members help inform priorities, challenge assumptions and test whether research, methodologies and practical outputs remain relevant to policy, regulatory and operational realities.
Henry Ames
General Manager, Supply-Chain Work-Management, ZoomLogi
Advisory Board member supporting HCI’s supply-chain and operational perspective.
Maarten Van Baelen
Healthcare Policy and Advocacy Executive
Connects science, strategy and EU health systems.
David Earnshaw
Public Policy and Communications Professional
Senior European policy experience, with senior roles at the European Parliament, GSK, Oxfam, MSD and Burson (CEO and Chair 2002–2016); Senior Adviser at BOLDT BPI.
Stephan Gotthardt
Senior Supply-Chain, Transformation and Restructuring Executive
Former SVP EU Supply Chain at Teva and Managing Director of Merckle GmbH.
Nina Heinz
Senior Logistics and Life-Sciences Supply-Chain Executive
Advisory Board member supporting HCI’s logistics and life-sciences perspective.
Gregory van Lier
Independent Researcher
Strategic science, climate and EU policy expert.
Eduardo Pisani
Public Affairs, Health Policy and Market-Access Executive
Advisory Board member supporting HCI’s policy and market-access perspective.
Milena Richter
Public Affairs Leader
Extensive EU and pharmaceutical-policy experience.
Annabel Seebohm
Founder and Chief Executive, Health4.EU
Former Secretary General of COCIR and CPME.
Prof. Dr. DI Christa Wirthumer-Hoche
Regulatory-Affairs Expert
Former Head of the Austrian Medicines Agency and former Chair of the EMA Management Board.
Members
HCI members contribute evidence, expertise and operational experience to questions affecting the healthcare value chain as a whole. Membership connects organisations from different parts of the chain around work that no single member could complete alone.
Our Structure
HCI is established as an AISBL in Belgium. Its statutory bodies provide formal oversight; its leadership and secretariat guide the programme and administration; the Advisory Board brings independent challenge; and working groups develop the thematic work with members and invited experts.
Part of HCI
Role
General Assembly / Board
Formal governance and oversight — exact naming to be confirmed against the statutes.
Leadership and secretariat
Programme direction, operations, administration and external engagement.
Advisory Board
Independent advice, challenge and relevance testing.
Working Groups
Evidence, analysis and practical outputs across PACS, ESG and DIGI.
Members and invited experts
Experience, evidence and perspectives from across the healthcare value chain.